周四，H.C. Wainwright维持对Adicet Bio Inc. (NASDAQ: ACET)股票的中性立场，此前该公司宣布美国食品和药物管理局(FDA)同意修改其新药研究申请(IND)。这项修改将允许Adicet Bio在其正在进行的1期试验中评估其药物候选ADI-001对其他自身免疫性疾病的治疗效果。 Adicet Bio的同种异体γδ T细胞产品候选ADI-001包含一个抗CD20 ...

Adicet Bio ( (ACET) ) has provided an update. Adicet Bio has received FDA clearance to expand its investigational new drug ...

Amplo Biotechnology, a biotechnology company developing genetic medicines for the treatment of neuromuscular diseases, announced the presentation of three posters at the European Society of Gene and ...

加利福尼亚州红木城和马萨诸塞州波士顿 - 临床阶段生物技术公司Adicet Bio, Inc. (NASDAQ: ...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the U.S. Food and ...

In a report released today, Edward White from H.C. Wainwright reiterated a Hold rating on Adicet Bio (ACET – Research Report). The ...

At the time of his passing, Mboweni served as Chairperson of the African Center for Economic Transformation (ACET), a global ...

This used to be such a nice space to study and hang out … it was kind of a common vibe,” said Markel, “and now we don't have ...

On September 30, 2024, Millennium Management LLC, a prominent hedge fund, executed a significant transaction involving the ...